+986.4%
MRNA vs JBHT
+32.1%
+954.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | JBHT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.8% | +3.1% | +2.7% | +5.2% |
| 7D | +21.8% | +0.4% | +21.4% | +21.8% |
| 30D | +19.6% | -2.0% | +21.5% | +20.0% |
| 3M | +354.6% | -16.3% | +370.9% | +363.1% |
| 6M | +394.9% | -8.2% | +403.2% | +370.8% |
| YTD | +812.2% | +16.3% | +795.9% | +615.2% |
| All | +986.4% | +32.1% | +954.3% | +689.3% |
Cumulative growth
Daily Returns
Daily percentage return beside JBHT.
Daily Out/Under-Performance
Portfolio return minus JBHT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × JBHT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded JBHT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling